Brazil, Argentina, Mexico and others tighten pesticide rules, accelerating harmonization while raising compliance risks and market access stakes across LATAM.

The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

Multi-member independent agencies have been part of the U.S. government since its earliest days. For centuries, the U.S.

WASHINGTON — The goal of achieving universal health coverage by 2030 — one of the United Nations’ Sustainable Development Goals — necessitates that countries strengthen their food and drug regulatory ...

Regulation remains perhaps the biggest factor shaping the nascent alternative protein market. Forthcoming and unpredictable novel food approvals in cultivated meat can dissuade investors. However, ...

The advent of artificial intelligence (AI) is reshaping industries, societies, and global interactions at an unparalleled pace. As AI technologies continue to evolve, countries and institutions ...